On the other hand, PQQ is a relatively newer discovery and is classified as a redox cofactor. It plays a key role in cellular energy metabolism, stimulating mitochondrial biogenesis—the process by which new mitochondria are formed in the cells. PQQ has also been shown to exhibit potent antioxidant effects, protecting cells from damage and promoting overall cellular health.
Moreover, sevoflurane is particularly well-tolerated among pediatric patients. Its pleasant, fruity odor and non-irritating nature allow for smooth induction in children, who often exhibit anxiety when faced with anesthesia. Pediatric anesthesia is critical given the unique physiological considerations in children, and the adaptability of sevoflurane enhances its appeal within this demographic. Its ability to maintain hemodynamic stability further supports its use in patients with compromised cardiovascular status or in settings where maintaining blood pressure is crucial.